Literature DB >> 8024661

Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder.

M R Pranzatelli1, S H Mott, S G Pavlakis, J A Conry, E D Tate.   

Abstract

Parkinsonism is an uncommon movement disorder in childhood. Six unusual cases of acquired parkinsonism in hospitalized children are described. Clinical manifestations included an akinetic-rigid syndrome with and without tremor, the combination of parkinsonism and dystonia, and a parkinsonism-plus syndrome. Altered mental status, mutism, dysphagia, and sialorrhea were frequent associations. Etiologies included hypoxic-ischemic encephalopathy; haloperidol treatment with and without neuroleptic malignant syndrome; toxicity of cytosine arabinoside, cyclophosphamide, amphotericin B, and methotrexate; St. Louis encephalitis and other encephalitides; and a pineal tumor with hydrocephalus. Cranial magnetic resonance imaging results ranged from normal to profound cerebral and cerebellar atrophy with chemotherapeutic toxicity. The illnesses usually were severe enough to require pharmacotherapy. Incorrect diagnoses of depression or catatonia delayed treatment or aggravated the problem. Acute treatment included amantadine, levodopa/carbidopa with or without selegiline, diphenhydramine, or benztropine. The concentration of CSF homovanillic acid was normal in a neuroleptic-associated patient, but the level was low in an encephalitic patient. All patients demonstrated dramatic improvement, including two who were not treated; some had complete resolution of symptoms and none required continued antiparkinsonian drugs despite poor scores on the Unified Parkinson's Disease Rating Scale and the Modified Hoehn and Yahr Rating Scales. The causes of parkinsonism described are more common in a general pediatric hospital than the parkinsonism associated with the popularized Segawa syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024661     DOI: 10.1016/0887-8994(94)90045-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  11 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 3.  Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.

Authors:  Ajay Kumar; Karthikeyan Narayanan; Ravi Kumar Chaudhary; Sachin Mishra; Sundramurthy Kumar; Kumar Jayaseelan Vinoth; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

Review 4.  Neurologic complications of chemotherapy for children with cancer.

Authors:  Alyssa T Reddy; Kerry Witek
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

5.  Parkinson's Syndrome After Cranial Radiotherapy: A Case Report.

Authors:  Kati K Reddy; Mark D Anderson; Srinivasan Vijayakumar; Toms Vengaloor Thomas
Journal:  Cureus       Date:  2022-04-23

Review 6.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

7.  Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy.

Authors:  Raja Mehanna; Joohi Jimenez-Shahed; Ilia Itin
Journal:  Am J Case Rep       Date:  2016-12-02

Review 8.  A role for viral infections in Parkinson's etiology?

Authors:  Laura K Olsen; Eilis Dowd; Declan P McKernan
Journal:  Neuronal Signal       Date:  2018-04-16

Review 9.  Viruses and neurodegeneration.

Authors:  Li Zhou; Monica Miranda-Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-05-31       Impact factor: 4.099

10.  Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer.

Authors:  Rose Marie Mathew; Myrna R Rosenfeld
Journal:  Curr Treat Options Neurol       Date:  2007-07       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.